Lao People's Democratic Republic vs Lebanon: Access to anti-retroviral drugs, female
Lao People's Democratic Republic
71.0%
in 2024
Lebanon
69.0%
in 2024
Lao People's Democratic Republic rank
81st
Lebanon rank
84th
Access to anti-retroviral drugs, female over time
- Lao People's Democratic Republic
- Lebanon
How they compare
Lao People's Democratic Republic currently reports 71.0% against 69.0% in Lebanon, a difference of 2.0%.
The two have swapped places 1 time across 24 shared years of data; in 2000 it was Lebanon ahead.
Lao People's Democratic Republic ranks 81st and Lebanon ranks 84th of 141 countries.
Lebanon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lao People's Democratic Republic | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.7% | 17.0% | 9.3% | Lebanon |
| 2010s | 35.9% | 42.5% | 6.6% | Lebanon |
| 2020s | 61.6% | 66.8% | 5.2% | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Lao People's Democratic Republic or Lebanon?
- Lao People's Democratic Republic, at 71.0% against 69.0% in Lebanon as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Lao People's Democratic Republic and Lebanon?
- 2.0%, with Lao People's Democratic Republic ahead.
- How many years of comparable data are there for Lao People's Democratic Republic and Lebanon?
- 24 years are reported by both, from 2000 to 2024.
- How do Lao People's Democratic Republic and Lebanon rank globally for access to anti-retroviral drugs, female?
- Lao People's Democratic Republic ranks 81st and Lebanon ranks 84th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.